Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence

• by Rolf P Holm, Malthe F Wandall-Holm, Melinda Magyari

• July 20, 2024

An Oxidative Glial Profile as a Predictor of Disability and Cognitive Decline in Primary Progressive Multiple Sclerosis

• by Albert Miguela, Joana Maria Huertas-Pons, Clàudia Coll-Martinez, Ariadna Gifreu-Fraixinó, Judit Salavedra-Pont, Manuel Comabella, Luisa María Villar, Jordi Gich, Gary Álvarez-Bravo, Lluís Ramió-Torrentà, Ana Quiroga-Varela

• April 27, 2026

CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases

• March 11, 2026

• 3 min

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights

• by Esther Ganelin-Cohen, Yair Wexler, Sraya Kraus, Ayal Rozenberg

• May 1, 2026